Minimally Invasive Surgical Devices Market Size is Anticipated to Acquire USD 62.68 Billion by 2032 Growing at a CAGR of 8.2%
The Brainy Insights
9 min read
The Brainy Insights
The minimally invasive surgical devices market size is anticipated to grow from USD 28.50 Billion in 2022 to USD 62.68 Billion in 10 years. The market ought to witness a positive growth rate owing to increasing adoption of minimally invasive surgical devices in orthopaedic surgeries.
Newark, Nov. 29, 2023 (GLOBE NEWSWIRE) -- The Brainy Insights estimates that the global minimally invasive surgical devices market will grow from USD 28.50 Billion in 2022 to USD 62.68 Billion by 2032. The development of minimally invasive surgery over time is a tribute to human creativity and the unwavering quest of medical progress. Since endoscopy was first developed in the early 20th century, the idea of minimally invasive surgery has existed. A wide range of medical devices, methods, and procedures are included in the category of minimally invasive surgical devices. Their practice design minimizes interruption to the patient's body during surgical procedures. With tiny incisions, specialized instruments, and cutting-edge imaging technologies, minimally invasive surgical device devices enable practised interventions with less trauma than traditional opеn surgery, which involves hugging incisions and considerable tissue disruption. These devices include a wide range of minimally invasive tools, such as endoscopes, laparoscopic instruments, robotic surgical systems and others.
Key Insight of the Minimally Invasive Surgical Devices Market
Asia-Pacific region is expected to grow at the highest CAGR during the forecast period.
During the forecast period, Asia-Pacific is expected to grow at the highest CAGR within the global Minimally invasive surgical devices market. The Asia-Pacific region would significantly expand. Nations like China, India, and Japan are rapidly investing on their healthcare infrastructure. The regional market expansion is anticipated to be aided by the economic development of nations like Japan and India. The Asia-Pacific region has a sizable population and a low per capita income, creating demand for reasonable treatment choices. International corporations aim to invest in developing nations like China and India to strengthen their market positions. As a result, the industry is growing because of the numerous partnerships and strategic alliances generating profitable growth prospects. Moreover, the government initiatives towards improving the overall medical/healthcare industry are anticipated to provide lucrative growth opportunities in upcoming years.
The electrosurgical devices segment is expected to grow at the highest CAGR during the forecast period.
The device type segment includes handheld instruments, inflation devices, cutter instruments, guiding devices, electrosurgical devices and others. The electrosurgical devices segment is expected to grow at the highest CAGR during the forecast period. Electrosurgical instruments are essential in minimally invasive surgery because they allow tissue dissection, coagulation, and cutting with electrical energy. These instruments include electromagnetic units, radiofrequency ablation systems, and sophisticated energy-based platforms, among other tools. Because electrosurgical devices are widely used in various minimally invasive procedures, especially in fields like urology, gynecology, and general surgery, they hold a significant market share in the global minimally invasive surgical devices industry. Achieving hemostasis, decreasing blood loss, and reducing persistent complications all depend on these devices.
The distillation segment is expected to hold the second largest market share.
The end-user segment is divided into ambulatory surgical centers and hospitals. The ambulatory surgical centers segment is expected to hold the second largest market share. In the global minimally invasive surgical devices market, ambulatory surgical centres have consistently grown their market share, especially in specializations that profit from their efficiency and affordability. Ambulatory surgical centres are widely used in several disciplines, including minor orthopaedic treatments, cataract surgery, and gastrointestinal endoscopy. Ambulatory surgical centres also do robotic-assisted surgery, which is becoming more common in gynaecology and urology. These facilities provide patients with the benefits of robotic surgery in an affordable and practical environment. Procedures that don't call for prolonged inpatient stays or prolonged care are particularly well-suited for ASCs. Patients frequently choose ASCs because of their simplified processes and quicker recovery times, which helps explain why their market share is growing.
The cardiac segment is expected to grow at the highest CAGR during the forecast period.
The application segment is divided into cardiac, gastrointestinal, orthopedic, gynaecological, neurological and others. The cardiac segment is expected to augment the market during the forecast period. Given the crucial nature of heart-related procedures and the requirements for practice interventions, cardiac surgery holds a significant market share in the global minimally invasive surgical devices market. To minimize stress to the heart and lower the risk of complications, cardiac surgery undertakes complex procedures through small incisions using sophisticated technologies like robotic-assisted systems and surgical devices. Reduced length of stay in the hospital and quicker recovery have been two benefits of using minimally invasive procedures in heart surgery. The market is still seeing advancements in device development, like more advanced imaging modalities and smaller robotic systems, contributing to the segment growth in the present scenario.
The pandemic's most noticeable and immediate effects included the postponement or cancellation of educational procedures. Due to the increase in COVID-19 cases, hospitals had to give infected patients critical treatment top priority. As a result, numerous environmental surveys—many of which were minimally invasive procedures—were postponed. Surgery scheduled for patients with conditions such as haemorrhagic repair, joint replacement, or gynaecological issues was rescheduled for some. Longer waiting lists and fewer patient access to minimally invasive surveillance resulted in this delay. Patients who had high hopes for the advantages of minimally invasive procedures still had to deal with chronic pain, discomfort, and limits in their day-to-day activities.
As the pandemic reduced in-person medical appointments, telemedicine became an important means of continuing patient consultations and care. But not all aspects of health care can benefit from telemedicine, particularly when it comes to surveillance. Many patients used virtual platforms for prospective follow-ups and surveillance consultations, but surgical procedures could not be performed remotely. While crucial for practicing patient care during the epidemic, telemedicine was unable to completely replace the advantages of minimally invasive surgery, which included quicker recovery periods, shorter hospital stays, and fewer complications following surgery.
Market Dynamics
Driver: Expansion of Indications
The ongoing expansion of minimally invasivе process indications is a significant factor propelling the global market for the global minimally invasivе surgery devices market. Minimally invasive surgery was initially mostly used for specific, standard operations. However, the range of procedures that can be carried out minimally or extensively has expanded due to advances in technology and methodology. Minimally invasivе techniques are currently being actively used to undertake complex surgeries that were previously only open procedures. Robotic-assisted urology operations, minimally invasivе spine surgery, and minimally invasivе cardiac surgery are among the examples. Healthcare professionals now have more opportunities to recommend minimally invasive surgery as a treatment option to a wider group of patients due to the abovementioned indications. This factor is boosting the market growth and development.
Restraint: Lack of Skilled Expertise
Adopting minimally invasivе surveillance may be hindered by health care personnel's lack of experience. Not all medical professionals, including surgeons, have undergone training in or experience minimally invasive techniques. Because minimally invasive surgical procedure requires significant learning and substantial training, medical experts who have spent years performing surgical procedures may be reluctant to switch to this new technology. Similarly, hospitals might not have the skilled personnel or surgical tools necessary to establish minimally invasive operations. The availability of minimally invasive procedures in some areas and healthcare facilities may be restricted due to a lack of competence. These factors may limit the market growth.
Opportunity: Adoption of Salt-Free and Alternative Water Softening Solutions
Adopting minimally invasivе surveillance may be hindered by health care personnel's lack of experience. Not all medical professionals, including surgeons, have undergone training in or experience minimally invasive techniques. Because minimally invasive surgical procedure requires significant learning and substantial training, medical experts who have spent years performing surgical procedures may be reluctant to switch to this new technology. Similarly, hospitals might not have the skilled personnel or surgical tools necessary to establish minimally invasive operations. The availability of minimally invasive procedures in some areas and healthcare facilities may be restricted due to a lack of competence. This factor is anticipated to provide lucrative market growth opportunities in the upcoming years.
Some of the major players operating in the Minimally Invasive Surgical Devices Market are:
• Terumo Medical Corp. • Edwards Lifesciences Corp. • Intuitive Surgical, Inc. • Abbott Laboratories, Inc. • Stryker Corp. • Teleflex, Inc. • Johnson & Johnson Services, Inc. • Smith & Nephew Plc • Sterimed Group • Medtronic plc • Zimmer Biomet Holdings, Inc. • Boston Scientific Corp.
• North America (U.S., Canada, Mexico) • Europe (Germany, France, the U.K., Italy, Spain, Rest of Europe) • Asia-Pacific (China, Japan, India, Rest of APAC) • South America (Brazil and the Rest of South America) • The Middle East and Africa (UAE, South Africa, Rest of MEA)
The market is analyzed based on value (USD Billion). All the segments have been analyzed worldwide, regional, and country basis. The study includes the analysis of more than 30 countries for each part. The report analyzes driving factors, opportunities, restraints, and challenges to gain critical market insight. The study includes porter's five forces model, attractiveness analysis, product analysis, supply, and demand analysis, competitor position grid analysis, distribution, and marketing channel analysis.
About The Brainy Insights:
The Brainy Insights is a market research company, aimed at providing actionable insights through data analytics to companies to improve their business acumen. We have a robust forecasting and estimation model to meet the clients' objectives of high-quality output within a short span of time. We provide both customized (clients' specific) and syndicate reports. Our repository of syndicate reports is diverse across all the categories and sub-categories across domains. Our customized solutions are tailored to meet the clients' requirement whether they are looking to expand or planning to launch a new product in the global market.
